AstraZeneca Zomig nasal spray formulation
Executive Summary
FDA approves nasal spray formulation of AstraZeneca's migraine therapy Zomig (zolmitriptan) Sept. 30. The new formulation is latest line extension to Zomig portfolio, which comprises conventional tablets and orally disintegrating tablets...